1Keeley EC, Boura JA, Grines CL Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet, 2003, 361 (9351) :13-20.
2The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. New Engl J Med, 1993,329(10) :673-682.
3Collen D, Lijnen HR. Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential. Blood, 1994,84 (3) :680-686.
4Schlott B, Hartmann M, Guhrs KH, et al. High yield production and purification of recombinant staphylokinase for thrombolytic therapy. Biotechnology, 1994, 12 ( 3 ) : 185-189.
5Collen D, Van de Weft F. Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction. Circulation, 1993,87(6) :1850-1853.
6Vanderschueren S, Barrios L, Kerdsinchai P, et al. for the STAR Trial Group. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. Circulation, 1995,92(8) :2044-2049.
7Vanderschueren S, Dens J, Kerdsinchai P, et al. Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction. Am Heart J, 1997,134(2 Pt 1 ) :213-219.
8Armstrong PW, Burton JR, Palisaitis D, et al. Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS). Am Heart J, 2000,139(5) :820-823.
9The GUSTO Angiographic Investigators. The effects of tissueplasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med, 1993,329(22) :1615-1622.
10Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revice the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction ) . Circulation, 2004,110 (9) : e82-e292.
